These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10864618)

  • 1. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.
    Giess R; Naumann M; Werner E; Riemann R; Beck M; Puls I; Reiners C; Toyka KV
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):121-3. PubMed ID: 10864618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.
    Bushara KO
    Med Hypotheses; 1997 Apr; 48(4):337-9. PubMed ID: 9160288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA; Panebianco M; Casabona A; Lanza S; Marchese-Ragona R; Patti F; Masiero S; Biondi A; Quartarone A
    Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29382036
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment.
    Stokholm MG; Bisgård C; Vilholm OJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):516-20. PubMed ID: 23984863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
    Weikamp JG; Schinagl DA; Verstappen CC; Schelhaas HJ; de Swart BJ; Kalf JG
    Acta Neurol Scand; 2016 Sep; 134(3):224-31. PubMed ID: 26803950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Tan EK; Lo YL; Seah A; Auchus AP
    J Neurol Sci; 2001 Sep; 190(1-2):95-7. PubMed ID: 11574113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
    Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
    Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.
    Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease.
    Dogu O; Apaydin D; Sevim S; Talas DU; Aral M
    Clin Neurol Neurosurg; 2004 Mar; 106(2):93-6. PubMed ID: 15003297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
    Guidubaldi A; Fasano A; Ialongo T; Piano C; Pompili M; Mascianà R; Siciliani L; Sabatelli M; Bentivoglio AR
    Mov Disord; 2011 Feb; 26(2):313-9. PubMed ID: 21259343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach.
    Winterholler MG; Erbguth FJ; Wolf S; Kat S
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):417-8. PubMed ID: 11248905
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
    Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study].
    Hernández-Palestina MS; Cisneros-Lesser JC; Arellano-Saldaña ME; Plascencia-Nieto SE
    Cir Cir; 2016; 84(6):459-468. PubMed ID: 27221328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis.
    Manrique D
    Braz J Otorhinolaryngol; 2005; 71(5):566-9. PubMed ID: 16612515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.